|
2026-06-05 |
2026-06-05 |
S
Sale
|
See Remarks
Officer
|
72,847
-18.5%
499.19
US$3,005,620
|
72,847
-18.5%
|
499.19
|
US$3,005,620
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
Large shareholder
|
19,694
-45.1%
133.98
US$3,094,206
|
19,694
-45.1%
|
133.98
|
US$3,094,206
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
Large shareholder
|
97,430
-35.1%
10.48
US$2,744,131
|
97,430
-35.1%
|
10.48
|
US$2,744,131
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
Chief Financial Officer
Officer
|
35,000
-12.3%
58.75
US$2,056,250
|
35,000
-12.3%
|
58.75
|
US$2,056,250
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
Chief Financial Officer
Officer
|
35,000
-12.3%
58.75
US$2,056,250
|
35,000
-12.3%
|
58.75
|
US$2,056,250
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
Large shareholder
|
14,669,771
-35.1%
58.45
US$857,492,124
|
14,669,771
-35.1%
|
58.45
|
US$857,492,124
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
Large shareholder
|
14,669,771
-35.1%
58.45
US$857,492,124
|
14,669,771
-35.1%
|
58.45
|
US$857,492,124
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
See Remarks
Executive Director
|
130,000
-100.0%
58.75
US$7,637,500
|
130,000
-100.0%
|
58.75
|
US$7,637,500
|
|
|
2026-06-05 |
2026-06-05 |
S
Sale
|
See Remarks
Executive Director
|
130,000
-9.8%
58.75
US$7,637,500
|
130,000
-9.8%
|
58.75
|
US$7,637,500
|
|
|
2026-06-03 |
2026-06-03 |
PrS
Proposed sale
|
Former Officer
Officer
|
62,608
60.27
US$3,773,232
|
62,608
|
60.27
|
US$3,773,232
|
|
|
2026-06-02 |
2026-06-02 |
PrS
Proposed sale
|
Former Officer
Officer
|
9,201
59.95
US$551,567
|
9,201
|
59.95
|
US$551,567
|
|
|
2026-03-06 |
2026-03-04 |
S
Sale
|
See Remarks
Officer
|
30,000
-21.3%
41.15
US$1,234,500
|
30,000
-21.3%
|
41.15
|
US$1,234,500
|
|
|
2026-03-06 |
2026-03-04 |
S
Sale
|
See Remarks
Executive Director
|
220,000
-17.7%
41.15
US$9,053,000
|
220,000
-17.7%
|
41.15
|
US$9,053,000
|
|
|
2026-03-06 |
2026-03-04 |
S
Sale
|
Chief Financial Officer
Officer
|
35,000
-15.1%
41.15
US$1,440,250
|
35,000
-15.1%
|
41.15
|
US$1,440,250
|
|
|
2026-03-04 |
2026-03-04 |
S
Sale
|
Large shareholder
|
19,715,000
-31.8%
40.96
US$807,546,115
|
19,715,000
-31.8%
|
40.96
|
US$807,546,115
|
|
|
2026-03-04 |
2026-03-04 |
S
Sale
|
Large shareholder
|
19,715,000
-31.8%
40.96
US$807,546,115
|
19,715,000
-31.8%
|
40.96
|
US$807,546,115
|
|
|
2025-10-22 |
2025-10-22 |
S
Sale
|
Large shareholder
|
14,745,000
-19.1%
28.78
US$424,390,590
|
14,745,000
-19.1%
|
28.78
|
US$424,390,590
|
|
|
2025-10-22 |
2025-10-22 |
S
Sale
|
Large shareholder
|
14,745,000
-19.1%
28.78
US$424,390,590
|
14,745,000
-19.1%
|
28.78
|
US$424,390,590
|
|
|
2025-10-22 |
2025-10-22 |
S
Sale
|
See Remarks
Executive Director
|
235,000
-17.2%
28.78
US$6,763,770
|
235,000
-17.2%
|
28.78
|
US$6,763,770
|
|
|
2025-10-22 |
2025-10-22 |
S
Sale
|
See Remarks
Officer
|
20,000
-13.2%
28.78
US$575,640
|
20,000
-13.2%
|
28.78
|
US$575,640
|
|
|
2025-08-14 |
2025-08-14 |
PrS
Proposed sale
|
Former Officer
Officer
|
16,168
22.40
US$362,241
|
16,168
|
22.40
|
US$362,241
|
|
|
2025-06-26 |
2025-06-24 |
S
Sale
|
Large shareholder
|
2,100,000
-2.7%
21.15
US$44,418,990
|
2,100,000
-2.7%
|
21.15
|
US$44,418,990
|
|
|
2025-06-26 |
2025-06-24 |
S
Sale
|
Large shareholder
|
2,100,000
-2.7%
21.15
US$44,418,990
|
2,100,000
-2.7%
|
21.15
|
US$44,418,990
|
|
|
2025-06-16 |
2025-06-12 |
S
Sale
|
Large shareholder
|
13,288,101
-14.3%
21.15
US$281,068,584
|
13,288,101
-14.3%
|
21.15
|
US$281,068,584
|
|
|
2025-06-16 |
2025-06-12 |
S
Sale
|
Large shareholder
|
13,288,101
-14.3%
21.15
US$281,068,584
|
13,288,101
-14.3%
|
21.15
|
US$281,068,584
|
|
|
2025-06-13 |
2025-06-12 |
S
Sale
|
President, Community Living
Officer
|
30,730
-43.9%
21.75
US$668,378
|
30,730
-43.9%
|
21.75
|
US$668,378
|
|
|
2025-06-13 |
2025-06-12 |
S
Sale
|
See Remarks
Officer
|
14,415
-9.9%
21.75
US$313,526
|
14,415
-9.9%
|
21.75
|
US$313,526
|
|
|
2025-06-13 |
2025-06-12 |
S
Sale
|
See Remarks
Officer
|
119,298
-36.5%
21.75
US$2,594,732
|
119,298
-36.5%
|
21.75
|
US$2,594,732
|
|
|
2025-06-13 |
2025-06-12 |
S
Sale
|
Chief Accounting Officer
Officer
|
15,616
-6.4%
21.75
US$339,648
|
15,616
-6.4%
|
21.75
|
US$339,648
|
|
|
2025-06-13 |
2025-06-12 |
S
Sale
|
See Remarks
Executive Director
|
531,840
-31.0%
21.75
US$11,567,520
|
531,840
-31.0%
|
21.75
|
US$11,567,520
|
|
|
2025-02-20 |
2025-02-18 |
S
Sale
|
Former 10% owner
|
12,000,000
-51.6%
21.16
US$253,920,000
|
12,000,000
-51.6%
|
21.16
|
US$253,920,000
|
|
|
2025-02-18 |
2025-02-18 |
PrS
Proposed sale
|
10% Stockholder
Large shareholder
|
12,000,000
22.15
US$265,800,000
|
12,000,000
|
22.15
|
US$265,800,000
|
|
|
2024-09-13 |
2024-09-11 |
S
Sale
|
Large shareholder
|
11,619,998
-33.3%
129,330,577.74
US$1,502,821,054,677,644
|
11,619,998
-33.3%
|
129,330,577.74
|
US$1,502,821,054,677,644
|
|
|
2024-09-13 |
2024-09-11 |
B
Purchase
|
Large shareholder
|
11,619,998
+14.3%
11.13
US$129,330,578
|
11,619,998
+14.3%
|
11.13
|
US$129,330,578
|
|
|
2024-09-13 |
2024-09-11 |
B
Purchase
|
Large shareholder
|
11,619,998
+14.3%
11.13
US$129,330,578
|
11,619,998
+14.3%
|
11.13
|
US$129,330,578
|
|
|
2024-05-21 |
2024-05-20 |
B
Purchase
|
Non-Executive Director
|
1,000
+inf%
11.46
US$11,461
|
1,000
+inf%
|
11.46
|
US$11,461
|
|
|
2024-03-18 |
2024-03-15 |
B
Purchase
|
President, PharMerica
Officer
|
3,000
+5.2%
8.21
US$24,630
|
3,000
+5.2%
|
8.21
|
US$24,630
|
|
|
2024-03-18 |
2024-03-15 |
B
Purchase
|
See Remarks
Officer
|
6,080
+4.7%
8.26
US$50,221
|
6,080
+4.7%
|
8.26
|
US$50,221
|
|
|
2024-03-18 |
2024-03-15 |
B
Purchase
|
See Remarks
Executive Director
|
18,400
+5.2%
8.09
US$148,856
|
18,400
+5.2%
|
8.09
|
US$148,856
|
|
|
2024-03-18 |
2024-03-15 |
B
Purchase
|
See Remarks
Executive Director
|
18,400
+1.8%
8.09
US$148,856
|
18,400
+1.8%
|
8.09
|
US$148,856
|
|
|
2024-03-15 |
2024-03-14 |
B
Purchase
|
See Remarks
Executive Director
|
37,405
+1921.2%
8.12
US$303,729
|
37,405
+1921.2%
|
8.12
|
US$303,729
|
|
|
2024-03-15 |
2024-03-14 |
B
Purchase
|
See Remarks
Officer
|
12,280
+10.5%
8.18
US$100,450
|
12,280
+10.5%
|
8.18
|
US$100,450
|
|
|
2024-03-15 |
2024-03-14 |
B
Purchase
|
Chief Accounting Officer
Officer
|
12,300
+8.0%
8.14
US$100,122
|
12,300
+8.0%
|
8.14
|
US$100,122
|
|